Offshore
Photo
Stock Analysis Compilation
Bell AM on Core & Main $CNM US
Thesis: Core & Main is a mid-cap US industrial company well-positioned for growth through market share gains, mergers, and attractive valuation, promising solid double-digit earnings growth.
(Extract from their October letter) https://t.co/UeXo0EgCpo
tweet
Bell AM on Core & Main $CNM US
Thesis: Core & Main is a mid-cap US industrial company well-positioned for growth through market share gains, mergers, and attractive valuation, promising solid double-digit earnings growth.
(Extract from their October letter) https://t.co/UeXo0EgCpo
tweet
Offshore
Photo
Capital Employed
Q4 2024 Fund Letters Round-Up has just been published.
Some amazing annual performances. One fund achieved a 101% return 😲
https://t.co/Dndl7wcMwK https://t.co/unsqIkpdep
tweet
Q4 2024 Fund Letters Round-Up has just been published.
Some amazing annual performances. One fund achieved a 101% return 😲
https://t.co/Dndl7wcMwK https://t.co/unsqIkpdep
tweet
Offshore
Photo
Dimitry Nakhla | Babylon Capital®
$FICO is quietly down -20% from its highs https://t.co/aJtHu5h23U
tweet
$FICO is quietly down -20% from its highs https://t.co/aJtHu5h23U
tweet
Offshore
Photo
Offshore
Photo
InsideArbitrage
Johnson & Johnson $JNJ is in talks to acquire Intra-Cellular Therapies $ITCI, a biopharmaceutical company focused on treating central nervous system disorders - Bloomberg
A deal could be reached as soon as this week. While ongoing discussions may not lead to an agreement, other suitors could also emerge.
tweet
Johnson & Johnson $JNJ is in talks to acquire Intra-Cellular Therapies $ITCI, a biopharmaceutical company focused on treating central nervous system disorders - Bloomberg
A deal could be reached as soon as this week. While ongoing discussions may not lead to an agreement, other suitors could also emerge.
tweet
Offshore
Photo
Hidden Value Gems
Interesting points from co-CIO of Bridgewater Associates Karen Karniol-Tambur:
1⃣"US equities in aggregate need 9% annualised EPS growth to earn a normal return above bonds; the rest of the world needs only 2.5% annualised growth."
2⃣"Tech is priced for higher earnings than the rest of the S&P, though without much difference between Al and non-Al names."
3⃣"Other than India, EM equities require no EPS growth for a normal return above bonds."
#Stocks #StockMarket #Equity
tweet
Interesting points from co-CIO of Bridgewater Associates Karen Karniol-Tambur:
1⃣"US equities in aggregate need 9% annualised EPS growth to earn a normal return above bonds; the rest of the world needs only 2.5% annualised growth."
2⃣"Tech is priced for higher earnings than the rest of the S&P, though without much difference between Al and non-Al names."
3⃣"Other than India, EM equities require no EPS growth for a normal return above bonds."
#Stocks #StockMarket #Equity
tweet
Offshore
Photo
Stock Analysis Compilation
Baron Emerging Markets Fund on ISC Co $095340 KS
Thesis: ISC Co., Ltd. is poised to benefit from the shift to elastomer test sockets in semiconductor testing, leveraging its market dominance and strong growth linked to the AI and high-performance computing sectors.
(Extract from their Q3 letter)
tweet
Baron Emerging Markets Fund on ISC Co $095340 KS
Thesis: ISC Co., Ltd. is poised to benefit from the shift to elastomer test sockets in semiconductor testing, leveraging its market dominance and strong growth linked to the AI and high-performance computing sectors.
(Extract from their Q3 letter)
tweet
Offshore
Photo
Hidden Value Gems
"As 2024 began, the average return forecast for the S&P 500 was 7.4% by stock analysts and 1.3% by market strategists. The actual return, including dividends: 25.02%."
"For 2023, analysts predicted a 17.5% gain for the S&P 500; strategists, a 6.2% rise. The S&P realized a 26.3% increase, with dividends."
h/t @jasonzweigwsj
tweet
"As 2024 began, the average return forecast for the S&P 500 was 7.4% by stock analysts and 1.3% by market strategists. The actual return, including dividends: 25.02%."
"For 2023, analysts predicted a 17.5% gain for the S&P 500; strategists, a 6.2% rise. The S&P realized a 26.3% increase, with dividends."
h/t @jasonzweigwsj
tweet
Offshore
Photo
InsideArbitrage
Johnson & Johnson $JNJ to Acquire Intra-Cellular Therapies $ITCI for $14.6 Billion -
💊J&J will acquire all outstanding shares of Intra-Cellular for $132.00 per share in cash, representing a premium of 39.14% from the stock’s last close.
💊J&J expects to finance the deal, which is anticipated to close later this year, through a combination of cash on hand and debt.
tweet
Johnson & Johnson $JNJ to Acquire Intra-Cellular Therapies $ITCI for $14.6 Billion -
💊J&J will acquire all outstanding shares of Intra-Cellular for $132.00 per share in cash, representing a premium of 39.14% from the stock’s last close.
💊J&J expects to finance the deal, which is anticipated to close later this year, through a combination of cash on hand and debt.
tweet
Offshore
Video
Startup Archive
Facebook VP of Growth on how to prioritize power users vs marginal users
“The thing that everyone in the Valley gets wrong is that we think about ourselves when we optimize for growth… But what you need to focus on is the marginal user.”
As Alex Schultz explains, this doesn’t mean power users aren’t important:
“Building an incredible product is all about optimizing for the people who use your product the most. But if your goal is driving growth, the people who are using your product the most are not the users you have to worry about.”
He cites the growth accounting framework Facebook used to think about growth:
“We looked at new users, resurrected users (people who weren’t on Facebook for 30 days and came back), and churned users. The resurrected and churned numbers for pretty much every product I’ve ever seen dominate the new user count once you reach a sensible point of growth a couple years in… And [at Facebook] all those users who were churning and resurrecting had low friend counts… So the number one thing we needed to focus on was getting them to 10 friends.”
In sum, focus on power users to build an incredible product, and focus on the marginal user to accelerate growth.
Video source: @ycombinator (2014)
tweet
Facebook VP of Growth on how to prioritize power users vs marginal users
“The thing that everyone in the Valley gets wrong is that we think about ourselves when we optimize for growth… But what you need to focus on is the marginal user.”
As Alex Schultz explains, this doesn’t mean power users aren’t important:
“Building an incredible product is all about optimizing for the people who use your product the most. But if your goal is driving growth, the people who are using your product the most are not the users you have to worry about.”
He cites the growth accounting framework Facebook used to think about growth:
“We looked at new users, resurrected users (people who weren’t on Facebook for 30 days and came back), and churned users. The resurrected and churned numbers for pretty much every product I’ve ever seen dominate the new user count once you reach a sensible point of growth a couple years in… And [at Facebook] all those users who were churning and resurrecting had low friend counts… So the number one thing we needed to focus on was getting them to 10 friends.”
In sum, focus on power users to build an incredible product, and focus on the marginal user to accelerate growth.
Video source: @ycombinator (2014)
tweet